The endocrine function of adipose tissue: An update

Clinical Endocrinology

Volumn 64, Issue 4, 2006, Pages 355-365

  Ronti, Tiziana ^a   Lupattelli, Graziana ^a   Mannarino, Elmo ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ADIPOCYTOKINE; ADIPONECTIN; ADIPSIN; ANGIOTENSINOGEN; AROMATASE; C REACTIVE PROTEIN; CHOLESTEROL ESTER TRANSFER PROTEIN; HORMONE SENSITIVE LIPASE; INTERLEUKIN 6; LEPTIN; LIPOPROTEIN LIPASE; METALLOTHIONEIN; PERILIPIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PLASMINOGEN ACTIVATOR INHIBITOR 1; RESISTIN; RETINOL BINDING PROTEIN; STEROID HORMONE; STEROID REDUCTASE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ADIPOSE TISSUE; ANGIOGENESIS; APPETITE; ATHEROSCLEROSIS; AUTOCRINE EFFECT; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CYTOKINE PRODUCTION; ENDOCRINE FUNCTION; ENDOCRINE SYSTEM; ENERGY BALANCE; EXERCISE; FATTY ACID OXIDATION; FIBRINOLYSIS; HEMOSTASIS; HUMAN; HYPERTENSION; INFLAMMATION; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID METABOLISM; NONHUMAN; OBESITY; PARACRINE SIGNALING; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; WEIGHT REDUCTION;

ADIPOSE TISSUE; ATHEROSCLEROSIS; CYTOKINES; HUMANS; HYPERTENSION; INSULIN RESISTANCE; LIPID METABOLISM; OBESITY;

EID: 33644911756     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2006.02474.x     Document Type: Review

References (124)

1. Rande P.J. Garland P.B. Hales C.N. Newsholme E.A. 1963 The glucose-fatty acid cycle, its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus Lancet 1 785 789
2. Yki-Jarvinen H. 2002 Ectopic fat accumulation: an important cause of insulin resistance in humans Journal of the Royal Society of Medicine 95 39 45
3. Chaldakov G.N. Stankulov I.S. Hristova M. Ghenev P.I. 2003 Adipobiology of disease: adipokines and adipokine-targeted pharmacology Current Pharmaceutical Design 9 1023 1031
4. Marti A. Berraondo B. Martinez J.A. 1995 'Obese' protein slims mice Science 269 475 476
5. Ahima R.S. Saper C.B. Flier J.S. Elmquist J.K. 2000 Leptin regulation of neuroendocrine systems Front Neuroendocrinology 21 263 307
6. Minokoshi Y. Kim Y.B. 2002 Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinasi Nature 415 339 343
7. Ahima R.S. Kelly J. Elmquist J.K. Flier J.S. 1999 Distinct physiologic and neuronal responses to decreased leptin and mild hyperleptinemia Endocrinology 140 4923 4931
8. Flier J.S. 1998 Clinical review 94: what's in a name? In search of leptin's physiologic role Journal of Clinical Endocrinology and Metabolism 83 1407 1413
9. Chan J.L. Heist K. DePaoli A.M. Veldhuis J.D. Mantzoros C.S. 2003 The role of falling leptin levels in the neuroendocrine and metabolic adaptation to short-term starvation in healthy men Journal of Clinical Investigations 111 1409 1421
10. Wolfsdorf J. Sadeghi-Nejad A. Senior B. 2002 Leptin-replacement therapy in lipodystrophy New England Journal of Medicine 346 2008 2009
11. Farooqi I.S. Jebb S.A. Langmack G. Lawrence E. Cheetham C.H. Prentice A.M. Hughes I.A. McCamish M.A. O'Rahilly S. 1999 Effects of recombinant leptin therapy in a child with congenital leptin deficiency New England Journal of Medicine 341 879 884
12. Clement K. Vaisse C. Lahlou N. Cabrol S. Pelloux V. Cassuto D. 1998 A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction Nature 392 398 401
13. Bakker A.H. Van Dielen F.M. Greve J.W. Adam J.A. Buurman W.A. 2004 Preadipocyte number in omental and subcutaneous adipose tissue of obese individuals Obesity Research 12 488 498
14. Montez J.M. Soukas A. Asilmaz E. Fayzikhodjaeva G. Fantuzzi G. Friedman J.M. 2005 Acute leptin deficiency, leptin resistance, and the physiologic response to leptin withdrawal Proceedings of the National Academy of Sciences, USA 102 2537 2542
15. Wang Z. Zhou Y.T. Kakuma T. Lee Y. Kalra S.P. Kalra P.S. Pan W. Unger R.H. 2000 Leptin resistance of adipocytes in obesity: role of suppressors of cytokine signaling Biochemistry and Biophysics Research Communications 277 20 26
16. Farooqi I.S. Matarese G. Lord G.M. Keogh J.M. Lawrence E. Agwu C. Sanna V. Jebb S.A. Perna F. Fontana S. Lechler R.I. DePaoli A.M. O'Rahilly S. 2002 ) Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. Journal of Clinical Investigation 110 1093 1103
17. Wallace A.M. McMahon A.D. Packard C.J. Kelly A. Shepherd J. Gaw A. Sattar N. 2001 Plasma leptin and the risk of cardiovascular disease in the West of Scotland Coronary Prevention Study (WOSCOPS) Circulation 104 3052 3056
18. Sierra-Honigmann M.R. Nath A.K. Murakami C. Garcia-Cardena G. Papapetropoulos A. Sessa W.C. Madge L.A. Schechner J.S. Schwabb M.B. Polverini P.J. Flores-Riveros J.R. 1998 Biological action of leptin as an angiogenic factor Science 281 1683 1686
19. Bodary P.F. Westrick R.J. Wickenheiser K.J. Shen Y. Eitzman D.T. 2002 Effect of leptin on arterial thrombosis following vascular injury in mice Journal of the American Medical Association 287 1706 1709
20. Xu F.P. Chen M.S. Wang Y.Z. Yi Q. Lin S.B. Chen A.F. Luo J.D. 2004 Leptin induces hypertrophy via endothelin-1-reactive oxygen species pathway in cultured neonatal rat cardiomyocytes Circulation 110 1269 1275
21. Ouchi N. Kihara S. Funahashi T. Matsuzawa Y. Walsh K. 2003 Obesity, adiponectin and vascular inflammatory disease Current Opinions in Lipidology 14 561 566
22. Waki H. Yamauchi T. Kamon J. Ito Y. Uchida S. Kita S. Hara K. Hada Y. Vasseur F. Froguel P. Kimura S. Nagai R. Kadowaki T. 2003 Impaired multimerization of human adiponectin mutants associated with diabetes: molecular structure and multimer formation of adiponectin Journal of Biological Chemistry 278 40352 40363
23. Tsao T.S. Tomas E. Murrey H.E. Hug C. Lee D.H. Ruderman N.B. Heuser J.E. Lodish H.F. 2003 Role of disulfide bonds in Acrp30/adiponectin structure and signaling specificity: different oligomers activate different signal transduction pathways Journal of Biological Chemistry 278 50810 50817
24. Yamauchi T. Kamon J. Waki H. Imai Y. Shimozawa N. Hioki K. Uchida S. Ito Y. Takakuwa K. Matsui J. Takata M. Eto K. Terauchi Y. Komeda K. Tsunoda M. Murakami K. Ohnishi Y. Naitoh T. Yamamura K. Ueyama Y. Froguel P. Kimura S. Nagai R. Kadowaki T. 2003 Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosis Journal of Biological Chemistry 278 2461 2468
25. Ouchi N. Kihara S. Arita Y. Maeda K. Kuriyama H. Okamoto Y. Hotta K. Nishida M. Takahashi M. Nakamura T. Yamashita S. Funahashi T. Matsuzawa Y. 1999 Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin Circulation 100 2473 2476
26. Tan K.C. Xu A. Chow W.S. Lam M.C. Ai V.H. Tam S.C. Lam K.S. 2004 Hypoadiponectinemia is associated with impaired endothelium-dependent vasodilation Journal of Clinical Endocrinology and Metabolism 89 765 769
27. Bruun J.M. Lihn A.S. Verdich C. Pedersen S.B. Toubro S. Astrup A. Richelsen B. 2003 Regulation of adiponectin by adipose tissue-derived cytokines: in vivo and in vitro investigations in humans American Journal of Physiology, Endocrinology and Metabolism 285 E527 E533
28. Yamauchi T. Kamon J. Waki H. Terauchi Y. Kubota N. Hara K. Mori Y. Ide T. Murakami K. Tsuboyama-Kasaoka N. Ezaki O. Akanuma Y. Gavrilova O. Vinson C. Reitman M.L. Kagechika H. Shudo K. Yoda M. Nakano Y. Tobe K. Nagai R. Kimura S. Tomita M. Froguel P. Kadowaki T. 2001 The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity Nature Medicine 7 941 946
29. Yamauchi T. Kamon J. Minokoshi Y. Ito Y. Waki H. Uchida S. Yamashita S. Noda M. Kita S. Ueki K. Eto K. Akanuma Y. Froguel P. Foufelle F. Ferre P. Carling D. Kimura S. Nagai R. Kahn B.B. Kadowaki T. 2002 Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase Nature Medicine 8 1288 1295
30. Pischon T. Girman C.J. Hotamisligil G.S. Rifai N. Hu F.B. Rimm E.B. 2004 Plasma adiponectin levels and risk of myocardial infarction in men Journal of the American Medical Association 291 1730 1737
31. Schulze M.B. Shai I. Rimm E.B. Li T. Rifai N. Hu F.B. 2005 February Adiponectin and future coronary heart disease events among men with type 2 diabetes Diabetes 54 534 539
32. Howard B.V. Lee E.T. Cowan L.D. Devereux R.B. Galloway J.M. Go O.T. Howard W.J. Rhoades E.R. Robbins D.C. Sievers M.L. Welty T.K. 1999 Rising tide of cardiovascular disease in American Indians. The Strong Heart Study Circulation 11 99 2389 2395
33. Lindsay R.S. Resnick H.E. Zhu J. Tun M.L. Howard B.V. Zhang Y. Yeh J. Best L.G. 2005 Adiponectin and coronary heart disease: the Strong Heart Study Arteriosclerosis, Thrombosis and Vascular Biology 25 15 16
34. Lindsay R.S. Funahashi T. Hanson R.L. Matsuzawa Y. Tanaka S. Tataranni P.A. Knowler W.C. Krakoff J. 2002 Adiponectin and development of type 2 diabetes in the Pima Indian population Lancet 360 57 58
35. Spranger J. Kroke A. Mohlig M. Bergmann M.M. Ristow M. Boeing H. Pfeiffer A.F. 2003 Adiponectin and protection against type 2 diabetes mellitus Lancet 361 226 228
36. Iwaki M. Matsuda M. Maeda N. Funahashi T. Matsuzawa Y. Makishima M. Shimomura I. 2003 Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors Diabetes 52 1655 1663
37. Coppack S.W. 2001 Pro-inflammatory cytokines and adipose tissue Proceedings of the Nutrition Society 60 349 356
38. Katsuki A. Sumida Y. Murashima S. Murata K. Takarada Y. Ito K. Fujii M. Tsuchihashi K. Goto H. Nakatani K. Yano Y. 1998 Serum levels of tumor necrosis factor-alpha are increased in obese patients with noninsulin-dependent diabetes mellitus Journal of Clinical Endocrinology and Metabolism 83 859 862
39. Hotamisligil G.S. Shargill N.S. Spiegelman B.M. 1993 Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance Science 1 259 87 91
40. Yudkin J.S. Eringa E. Stehouwer C.D. 2005 'Vasocrine' signalling from perivascular fat: a mechanism linking insulin resistance to vascular disease Lancet 365 1817 1820
41. Jellema A. Plat J. Mensink R.P. 2004 Weight reduction, but not a moderate intake of fish oil, lowers concentrations of inflammatory markers and PAI-1 antigen in obese men during the fasting and postprandial state European Journal of Clinical Investigations 34 766 773
42. Ofei F. Hurel S. Newkirk J. Sopwith M. Taylor R. 1996 Effects of an engineered human anti-TNF-alpha antibody (CDP571) on insulin sensitivity and glycemic control in patients with NIDDM Diabetes 45 881 885
43. Ruan H. Miles P.D. Ladd C.M. Ross K. Golub T.R. Olefsky J.M. Lodish H.F. 2002 Profiling gene transcription in vivo reveals adipose tissue as an immediate target of tumor necrosis factor-alpha: implications for insulin resistance Diabetes 51 3176 3188
44. Boyle P.J. 2004 What are the effects of peroxisome proliferator-activated receptor agonists on adiponectin, tumor necrosis factor-alpha, and other cytokines in insulin resistance? Clinical Cardiology 27 1111 1116
45. Ridker P.M. Rifai N. Pfeffer M. Sacks F. Lepage S. Braunwald E. 2000 Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction Circulation 101 2149 2153
46. Cesari M. Penninx B.W. Newman A.B. Kritchevsky S.B. Nicklas B.J. Sutton-Tyrrell K. Rubin S.M. Ding J. Simonsick E.M. Harris T.B. Pahor M. 2003 Inflammatory markers and onset of cardiovascular events: results from the Health ABC study Circulation 108 2317 2322
47. Pai J.K. Pischon T. Ma J. Manson J.E. Hankinson S.E. Joshipura K. Curhan G.C. Rifai N. Cannuscio C.C. Stampfer M.J. Rimm E.B. 2004 Inflammatory markers and the risk of coronary heart disease in men and women New England Journal of Medicine 16 351 2599 2610
48. Ziccardi P. Nappo F. Giugliano G. Esposito K. Marfella R. Cioffi M. D'Andrea F. Molinari A.M. Giugliano D. 2002 Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year Circulation 105 804 809
49. Mohamed-Ali V. Pinkney J.K. 1998 Adipose tissue as an endocrine and paracrine organ International Journal of Obesity and Related Metabolism Disorders 22 1145 1158
50. Bellido T. Jilka R.L. Boyce B.F. Girasole G. Broxmeyer H. Dalrymple S.A. Murray R. Manolagas S.C. 1995 Regulation of interleukin-6, osteoclastogenesis, and bone mass by androgens. The role of the androgen receptor Journal of Clinical Investigation 95 2886 2895
51. Bernad A. Kopf M. Kulbacki R. Weich N. Koehler G. Gutierrez-Ramos J.C. 1994 Interleukin-6 is required in vivo for the regulation of stem cells and committed progenitors of the hematopoietic system Immunity 1 725 731
52. Romano M. Sironi M. Toniatti C. Polentarutti N. Fruscella P. Ghezzi P. Faggioni R. Luini W. van Hinsbergh V. Sozzani S. Bussolino F. Poli V. Ciliberto G. Mantovani A. 1997 Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment Immunity 6 315 325
53. Kozak W. Poli V. Soszynski D. Con n C.A. Leon L.R. Kluger M.J. 1997 Sickness behavior in mice deficient in interleukin-6 during turpentine abscess and influenza pneumonitis American Journal of Physiology 272 621 630
54. + T helper cell 1 development in interleukin 6-deficient mice infected with Candida albicans Journal of Experimental Medicine 183 1345 1355
55. Kopf M. Baumann H. Freer G. Freudenberg M. Lamers M. Kishimoto T. Zinkernagel R. Bluethmann H. Kohler G. 1994 Impaired immune and acute-phase responses in interleukin-6-deficient mice Nature 368 339 342
56. Bastard J.P. Jardel C. Bruckert E. Blondy P. Capeau J. Laville M. Vidal H. Hainque B. 2000 Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss Journal of Clinical Endocrinology and Metabolism 85 3338 3342
57. Esposito K. Pontillo A. Di Palo C. Giugliano G. Masella M. Marfella R. Giugliano D. 2003 Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial Journal of the American Medical Association 289 1799 1804
58. Mohamed-Ali V. Goodrick S. Rawesh A. Katz D.R. Miles J.M. Yudkin J.S. Klein S. Coppack S.W. 1997 Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo Journal of Clinical Endocrinology and Metabolism 82 4196 4200
59. Fried S.K. Bunkin D.A. Greenberg A.S. 1998 Omental and subcutaneous adipose tissues of obese subjects release interleukin-6. Depot difference and regulation by glucocorticoid Journal of Clinical Endocrinology and Metabolism 83 847 850
60. Tsigos C. Papanicolaou D.A. Kyrou I. Defensor R. Mitsiadis C.S. Chrousos G.P. 1997 Dose-dependent effects of recombinant human interleukin-6 on glucose regulation Journal of Clinical Endocrinology and Metabolism 82 4167 4170
61. Senn J.J. Klover P.J. Nowak I.A. Zimmers T.A. Koniaris L.G. Furlanetto R.W. Mooney R.A. 2003 Suppressor of cytokine signaling-3 (SOCS-3), a potential mediator of interleukin-6-dependent insulin resistance in hepatocytes Journal of Biological Chemistry 278 13740 13746
62. Rotter Sopasakis V. Larsson B.M. Johansson A. Holmang A. Smith U. 2004 Short-term infusion of interleukin-6 does not induce insulin resistance in vivo or impair insulin signalling in rats Diabetologia 47 1879 1887
63. Makino T. Noguchi Y. Yoshikawa T. Doi C. Nomura K. 1998 Circulating interleukin 6 concentrations and insulin resistance in patients with cancer British Journal of Surgery 85 1658 1662
64. Van Harmelen V. Reynisdottir S. Cianflone K. Degerman E. Hoffstedt J. Nilsell K. Sniderman A. Arner P. 1999 Mechanisms involved in the regulation of free fatty acid release from isolated human fat cells by acylation-stimulating protein and insulin Journal of Biological Chemistry 274 18243 18251
65. Maslowska M. Vu H. Phelis S. Sniderman A.D. Rhode B.M. Blank D. Cianflone K. 1999 Plasma acylation stimulating protein, adipsin and lipids in non-obese and obese populations European Journal of Clinical Investigations 29 679 686
66. Cianflone K. Xia Z. 2003 Critical review of acylation-stimulating protein physiology in humans and rodents Biochimica et Biophysica Acta 1609 127 143
67. Kildsgaard J. Zsigmond E. Chan L. Wetsel R.A. 1999 A critical evaluation of the putative role of C3adesArg (ASP) in lipid metabolism and hyperapobetalipoproteinemia Molecular Immunology 36 869 876
68. Cianflone K. Zhang X.J. Genest J. Jr. Sniderman A. 1997 Plasma acylation-stimulating protein in coronary artery disease Arteriosclerosis Thrombosis and Vascular Biology 17 1239 1244
69. Holcomb I.N. Kabakoff R.C. Chan B. Baker T.W. Gurney A. Henzel W. Nelson C. Lowman H.B. Wright B.D. Skelton N.J. Frantz G.D. Tumas D.B. Peale F.V. Jr. Shelton D.L. Hebert C.C. 2000 FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family EMBO Journal 19 4046 4055
70. Steppan C.M. Bailey S.T. Bhat S. Brown E.J. Banerjee R.R. Wright C.M. Patel H.R. Ahima R.S. Lazar M.A. 2001 The hormone resistin links obesity to diabetes Nature 409 307 312
71. Rajala M.W. Obici S. Scherer P.E. Rossetti L. 2003 Adipose-derived resistin and gut-derived resistin-like molecule-beta selectively impair insulin action on glucose production Journal of Clinical Investigations 111 225 230
72. Ukkola O. 2002 Resistin- a mediator of obesity-associated insulin resistance or an innocent bystander? European Journal of Endocrinology 147 571 574
73. Chen L. Nyomba B.L. 2003 Glucose intolerance and resistin expression in rat offspring exposed to ethanol in utero: modulation by postnatal high-fat diet Endocrinology 144 500 508
74. Savage D.B. Sewter C.P. Klenk E.S. Segal D.G. Vidal-Puig A. Con sidine R.V. O'Rahilly S. 2001 Resistin/Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor- action in humans Diabetes 50 2199 2202
75. Steppan C.M. Lazar M.A. 2004 The current biology of resistin Journal of International Medicine 255 439 447
76. Reilly M.P. Lehrke M. Wolfe M.L. Rohatgi A. Lazar M.A. Rader D.J. 2005 Resistin is an inflammatory marker of atherosclerosis in humans Circulation 111 932 939
77. Ghosh S. Singh A.K. Aruna B. Mukhopadhyay S. Ehtesham N.Z. 2003 The genomic organization of mouse resistin reveals major differences from the human resistin: functional implications Gene 305 27 34
78. Osawa H. Onuma H. Murakami A. Ochi M. Nishimiya T. Kato K. Shimizu I. Fujii Y. Ohashi J. Makino H. 2002 Systematic search for single nucleotide polymorphisms in the resistin gene. the absence of evidence for the association of three identified single nucleotide polymorphisms with Japanese type 2 diabetes Diabetes 51 863 866
79. Engert J.C. Vohl M.C. Williams S.M. Lepage P. Loredo-Osti J.C. Faith J. Dore C. Renaud Y. Burtt N.P. Villeneuve A. Hirschhorn J.N. Altshuler D. Groop L.C. Despres J.P. Gaudet D. Hudson T.J. 2002 5′ Flanking variants of resistin are associated with obesity Diabetes 51 1629 1634
80. Wang H. Chu W.S. Hemphill C. Elbein S.C. 2002 Human resistin gene: molecular scanning and evaluation of association with insulin sensitivity and type 2 diabetes in Caucasians Journal of Clinical Endocrinology and Metabolism 87 2520 2524
81. Patel L. Buckels A.C. Kinghorn I.J. Murdock P.R. Holbrook J.D. Plumpton C. Macphee C.H. Smith S.A. 2003 Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators Biochemistry and Biophysics Research Communications 300 472 476
82. Hotamisligil G. 2003 The irresistible biology of resistin Journal of Clinical Investigation 111 173 174
83. Janke J. Engeli S. Gorzelniak K. Luft F.C. Sharma A.M. 2002 Resistin gene expression in human adipocytes is not related to insulin resistance Obesity Research 10 1 5
84. Nagaev I. Smith U. 2001 Insulin resistance and type 2 diabetes are not related to resistin expression in human fat cells or skeletal muscle Biochemistry and Biophysics Research Communications 285 561 564
85. McTernan C.L. McTernan P.G. Harte A.L. Levick P.L. Barnett A.H. Kumar S. 2002 Resistin, central obesity, and type 2 diabetes Lancet 359 46 47
86. Alessi M.C. Peiretti F. Morange P. Henry M. Nalbone G. Juhan-Vague I. 1997 Production of plasminogen activator inhibitor by human adipose tissue: possible link between visceral fat accumulation and vascular disease Diabetes 46 860 867
87. Bastelica D. Morange P. Berthet B. Borghi H. Lacroix O. Grino M. Juhan-Vague I. Alessi M.C. 2002 Stromal cells are the main plasminogen activator inhibitor-1-producing cells in human fat: evidence of differences between visceral and subcutaneous deposits Arteriosclerosis Thrombosis and Vascular Biology 22 173 178
88. Festa A. D'Agostino R. Jr. Tracy R.P. Haffner S.M. 2002 April Insulin resistance atherosclerosis study. Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study Diabetes 51 1131 1137
89. Massiera F. Bloch-Faure M. Ceiler D. Murakami K. Fukamizu A. Gasc J.M. Quignard-Boulange A. Negrel R. Ailhaud G. Seydoux J. Meneton P. Teboul M. 2001 Adipose angiotensinogen is involved in adipose tissue growth and blood pressure regulation FASEB Journal 15 2727 2729
90. Ailhaud G. Fukamizu A. Massiera F. Negrel R. Saint-Marc P. Teboul M. 2000 Angiotensinogen, angiotensin II and adipose tissue development International Journal of Obesity and Related Metabolism Disorders 24 S33 S35
91. Rubin G.L. Zhao Y. Kalus A.M. Simpson E.R. 2000 Peroxisome proliferator receptor gamma ligands inhibit estrogen biosynthesis in human breast adipose tissue: possible implication for breast cancer therapy Cancer Research 60 1604 1608
92. Hemsell D.L. Grodin J.M. Brenner P.F. Siiteri P.K. MacDonald P.C. 1974 Plasma precursors of estrogen. Correlation of the extent of conversion of plasma androstenedione to estrone with age Journal of Clinical Endocrinology and Metabolism 38 476 479
93. Bjorntorp P. 1996 The regulation of adipose tissue distribution in humans International Journal of Obesity and Related Metabolism Disorders 20 291 302
94. Jones M.E. Thorburn A.W. Britt K.L. Hewitt K.N. Wreford N.G. Proietto J. Oz O.K. Leury B.J. Robertson K.M. Yao S. Simpson E.R. 2000 Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity Proceedings of the National Academy of Sciences, USA 97 12735 12740
95. Seckl J.R. 2004 11beta-hydroxysteroid dehydrogenases: changing glucocorticoid action Current Opinions in Pharmacology 4 597 602
96. Wang M. 2005 The role of glucocorticoid action in the pathophysiology of the metabolic syndrome Nutrition and Metabolism 2 2 3
97. Livingstone D.E. Jones G.C. Smith K. Jamieson P.M. Andrew R. Kenyon C.J. Walker B.R. 2000 Understanding the role of glucocorticoids in obesity: tissue-specific alterations of corticosterone metabolism in obese Zucker rats Endocrinology 141 560 563
98. Aoki K. Homma M. Hirano T. Oka K. Satoh S. Mukasa K. Ito S. Sekihara H. 2001 mRNA and enzyme activity of hepatic 11ß-hydroxysteroid dehydrogenase type 1 are elevated in C57BL/KsJ-db/db mice Life Science 69 2543 2549
99. Masuzaki H. Paterson J. Shinyama H. Morton N.M. Mullins J.J. Seckl J.R. Flier J.S. 2001 A transegenic model of visceral obesity and the metabolic syndrome Science 294 2166 2170
100. Wake D.J. Rask E. Livingstone D.E. Soderberg S. Olsson T. Walker B.R. 2003 Local and systemic impact of transcriptional up-regulation of 11β-hydroxysteroid dehydrogenase type 1 in adipose tissue in human obesity Journal of Clinical Endocrinology and Metabolism 88 3983 3988
101. Valsamakis G. Anwar A. Tomlinson J.W. Shackleton C.H. McTernan P.G. Chetty R. Wood P.J. Banerjee A.K. Holder G. Barnett A.H. Stewart P.M. Kumar S. 2004 11β-hydroxysteroid dehydrogenase type 1 activity in lean and obese males with type 2 diabetes mellitus Journal of Clinical Endocrinology and Metabolism 89 4755 4761
102. Libby P. 2000 Changing concepts of atherogenesis Journal of International Medicine 247 349 358
103. Landry D.B. Couper L.L. Bryant S.R. Lindner V. 1997 Activation of the NF- B and I B system in smooth muscle cells after rat arterial injury. Induction of vascular cell adhesion molecule-1 and monocyte chemoattractant protein-1 American Journal of Pathology 151 1085 1095
104. Iademarco M.F. McQuillan J.J& Dean D.C. 1993 Vascular cell adhesion molecule 1: contrasting transcriptional control mechanisms in muscle and endothelium Proceedings of the National Academy of Sciences, USA 90 3943 3947
105. Eck S.L. Perkins N.D. Carr D.P. Nabel G.J. 1993 Inhibition of phorbol ester-induced cellular adhesion by competitive binding of NF-B in vivo Molecular and Cellular Biology 13 6530 6536
106. Clesham G.J. Adam P.J. Proudfoot D. Flynn P.D. Efstathiou S Weissberg P.L. 1998 High adenoviral loads stimulate NFB-dependent gene expression in human vascular smooth muscle cells Gene Therapy 5 174 180
107. Xie Q.W. Kashiwabara Y. Nathan C. 1994 Role of transcription factor NF-B/Rel in induction of nitric oxide synthase Journal of Biological Chemistry 269 4705 4708
108. Goto M. Katayama K.I. Shirakawa F. Tanaka I. 1999 Involvement of NF-B p50/p65 heterodimer in activation of the human pro-interleukin-1β gene at two subregions of the upstream enhancer element Cytokine 11 16 28
109. O'Rourke L. Gronning L.M. Yeaman S.J. Shepherd P.R. 2002 Glucose-dependent regulation of cholesterol ester metabolism in macrophages by insulin and leptin Journal of Biological Chemistry 277 42557 42562
110. Yudkin J.S. Kumari M. Humphries S.E. Mohamed-Ali V. 2000 Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? Atherosclerosis 148 209 214
111. Ridker P.M. Rifai N. Rose L. Buring J.E. Cook N.R. 2002 Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events New England Journal of Medicine 347 1557 1565
112. Fukuhara A. Matsuda M. Nishizawa M. Segawa K. Tanaka M. Kishimoto K. Matsuki Y. Murakami M. Ichisaka T. Murakami H. Watanabe E. Takagi T. Akiyoshi M. Ohtsubo T. Kihara S. Yamashita S. Makishima M. Funahashi T. Yamanaka S. Hiramatsu R. Matsuzawa Y. Shimomura I. 2005 Visfatin: a protein secreted by visceral fat that mimics the effects of insulin Science 307 426 430
113. Stentz F.B. Umpierrez G.E. Cuervo R. Kitabchi A.E. 2004 Proinflammatory cytokines, markers of cardiovascular risks, oxidative stress, and lipid peroxidation in patients with hyperglycemic crises Diabetes 53 8 2079 2086
114. Gabriely I. Yang X.M. Cases J.A. Ma X.H. Rossetti L. Barzilai N. 2002 Hyperglycemia induces PAI-1 gene expression in adipose tissue by activation of the hexosamine biosynthetic pathway Atherosclerosis 160 115 122
115. Sobel B.E. 1999 Increased plasminogen activator inhibitor-1 and vasculopathy. A reconcilable paradox Circulation 99 2496 2498
116. Thogersen A.M. Jansson J.H. Boman K. Nilsson T.K. Weinehall L. Huhtasaari F. Hallmans G. 1998 High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial infarction in both men and women: evidence for the fibrinolytic system as an independent primary risk factor Circulation 98 2241 2247
117. Tham D.M. Martin-McNulty B. Wang Y.X. Wilson D.W. Vergona R. Sullivan M.E. Dole W. Rutledge J.C. 2002 Angiotensin II is associated with activation of NF-B-mediated genes and downregulation of PPARs Physiological Genomics 11 21 30
118. Cai H. Li Z. Dikalov S. Holland S.M. Hwang J. Jo H. Dudley Jr 2002 SC, Harrison DG NAD (P) H oxidase-derived hydrogen peroxide mediates endothelial nitric oxide production in response to angiotensin II Journal of Biological Chemistry 277 48311 48317
119. Widlansky M.E. Gokce N. Keaney J.F. Jr. Vita J.A. 2003 The clinical implications of endothelial dysfunction Journal of the American College of Cardiology 42 1149 1160
120. Jambrik Z. Venneri L. Varga A. Rigo F. Borges A. Picano E. 2004 Peripheral vascular endothelial function testing for the diagnosis of coronary artery disease American Heart Journal 148 684 689
121. Verma S. Li S.H. Wang C.H. Fedak P.W. Li R.K. Weisel R.D. Mickle D.A. 2003 Resistin promotes endothelial cell activation: further evidence of adipokine-endothelial interaction Circulation 108 736 740
122. Kawanami D. Maemura K. Takeda N. Harada T. Nojiri T. Imai Y. Manabe I. Utsunomiya K. Nagai R. 2004 Direct reciprocal effects of resistin and adiponectin on vascular endothelial cells: a new insight into adipocytokine-endothelial cell interactions Biochemistry and Biophysics Research Communications 314 415 419
123. Calabro P. Samudio I. Willerson J.T. Yeh E.T. 2004 Resistin promotes smooth muscle cell proliferation through activation of extracellular signal-regulated kinase 1/2 and phosphatidylinositol 3-kinase pathways Circulation 110 3335 3340
124. Pinkney J.H. Stehouwer C.D. Coppack S.W. Yudkin J.S. 1997 Endothelial dysfunction: cause of the insulin resistance syndrome Diabetes 46 S9 S13